282 related articles for article (PubMed ID: 27852846)
1. A Transformation-Defective Polyomavirus Middle T Antigen with a Novel Defect in PI3 Kinase Signaling.
Denis D; Rouleau C; Schaffhausen BS
J Virol; 2017 Jan; 91(2):. PubMed ID: 27852846
[TBL] [Abstract][Full Text] [Related]
2. The p110alpha isoform of phosphatidylinositol 3-kinase is essential for polyomavirus middle T antigen-mediated transformation.
Utermark T; Schaffhausen BS; Roberts TM; Zhao JJ
J Virol; 2007 Jul; 81(13):7069-76. PubMed ID: 17442716
[TBL] [Abstract][Full Text] [Related]
3. Transformation by Polyomavirus Middle T Antigen Involves a Unique Bimodal Interaction with the Hippo Effector YAP.
Rouleau C; Pores Fernando AT; Hwang JH; Faure N; Jiang T; White EA; Roberts TM; Schaffhausen BS
J Virol; 2016 Aug; 90(16):7032-7045. PubMed ID: 27194756
[TBL] [Abstract][Full Text] [Related]
4. Transformation-defective mutants of polyomavirus middle T antigen associate with phosphatidylinositol 3-kinase (PI 3-kinase) but are unable to maintain wild-type levels of PI 3-kinase products in intact cells.
Ling LE; Druker BJ; Cantley LC; Roberts TM
J Virol; 1992 Mar; 66(3):1702-8. PubMed ID: 1371171
[TBL] [Abstract][Full Text] [Related]
5. Signaling from polyomavirus middle T and small T defines different roles for protein phosphatase 2A.
Mullane KP; Ratnofsky M; Culleré X; Schaffhausen B
Mol Cell Biol; 1998 Dec; 18(12):7556-64. PubMed ID: 9819441
[TBL] [Abstract][Full Text] [Related]
6. Requirement for both Shc and phosphatidylinositol 3' kinase signaling pathways in polyomavirus middle T-mediated mammary tumorigenesis.
Webster MA; Hutchinson JN; Rauh MJ; Muthuswamy SK; Anton M; Tortorice CG; Cardiff RD; Graham FL; Hassell JA; Muller WJ
Mol Cell Biol; 1998 Apr; 18(4):2344-59. PubMed ID: 9528804
[TBL] [Abstract][Full Text] [Related]
7. Identification of regions in polyomavirus middle T and small t antigens important for association with protein phosphatase 2A.
Campbell KS; Auger KR; Hemmings BA; Roberts TM; Pallas DC
J Virol; 1995 Jun; 69(6):3721-8. PubMed ID: 7538174
[TBL] [Abstract][Full Text] [Related]
8. Lessons from polyoma middle T antigen on signaling and transformation: A DNA tumor virus contribution to the war on cancer.
Schaffhausen BS; Roberts TM
Virology; 2009 Feb; 384(2):304-16. PubMed ID: 19022468
[TBL] [Abstract][Full Text] [Related]
9. Inositol trisphosphate levels in cells expressing wild-type and mutant polyomavirus middle T antigens: evidence for activation of phospholipase C via activation of pp60c-src.
Gorga FR; Riney CE; Benjamin TL
J Virol; 1990 Jan; 64(1):105-12. PubMed ID: 2152807
[TBL] [Abstract][Full Text] [Related]
10. Differential effects of polyoma virus middle tumor antigen mutants upon gap junctional, intercellular communication.
Geletu M; Guy S; Greer S; Raptis L
Exp Cell Res; 2015 Aug; 336(2):223-31. PubMed ID: 26187405
[TBL] [Abstract][Full Text] [Related]
11. ShcA and Grb2 mediate polyoma middle T antigen-induced endothelial transformation and Gab1 tyrosine phosphorylation.
Ong SH; Dilworth S; Hauck-Schmalenberger I; Pawson T; Kiefer F
EMBO J; 2001 Nov; 20(22):6327-36. PubMed ID: 11707404
[TBL] [Abstract][Full Text] [Related]
12. Polyomavirus middle T-antigen is a transmembrane protein that binds signaling proteins in discrete subcellular membrane sites.
Zhou AY; Ichaso N; Adamarek A; Zila V; Forstova J; Dibb NJ; Dilworth SM
J Virol; 2011 Apr; 85(7):3046-54. PubMed ID: 21228238
[TBL] [Abstract][Full Text] [Related]
13. Studies of partially transforming polyomavirus mutants establish a role for phosphatidylinositol 3-kinase in activation of pp70 S6 kinase.
Dahl J; Freund R; Blenis J; Benjamin TL
Mol Cell Biol; 1996 Jun; 16(6):2728-35. PubMed ID: 8649380
[TBL] [Abstract][Full Text] [Related]
14. pp60c-src binding to polyomavirus middle T-antigen (MT) requires residues 185 to 210 of the MT sequence.
Brewster CE; Glover HR; Dilworth SM
J Virol; 1997 Jul; 71(7):5512-20. PubMed ID: 9188625
[TBL] [Abstract][Full Text] [Related]
15. Independent contributions of polyomavirus middle T and small T to the regulation of early and late gene expression and DNA replication.
Chen L; Wang X; Fluck MM
J Virol; 2006 Aug; 80(15):7295-307. PubMed ID: 16840310
[TBL] [Abstract][Full Text] [Related]
16. Mutation of a cysteine residue in polyomavirus middle T antigen abolishes interactions with protein phosphatase 2A, pp60c-src, and phosphatidylinositol-3 kinase, activation of c-fos expression, and cellular transformation.
Glenn GM; Eckhart W
J Virol; 1993 Apr; 67(4):1945-52. PubMed ID: 7680388
[TBL] [Abstract][Full Text] [Related]
17. Protein kinase B/Akt is activated by polyomavirus middle-T antigen via a phosphatidylinositol 3-kinase-dependent mechanism.
Meili R; Cron P; Hemmings BA; Ballmer-Hofer K
Oncogene; 1998 Feb; 16(7):903-7. PubMed ID: 9484781
[TBL] [Abstract][Full Text] [Related]
18. Transformation-defective polyoma middle T antigen mutants defective in PLCgamma, PI-3, or src kinase activation enhance ERK2 activation and promote retinoic acid-induced, cell differentiation like wild-type middle T.
Yen A; Cherington V; Schaffhausen B; Marks K; Varvayanis S
Exp Cell Res; 1999 May; 248(2):538-51. PubMed ID: 10222145
[TBL] [Abstract][Full Text] [Related]
19. Association of Polyomavirus middle tumor antigen with phospholipase C-gamma 1.
Su W; Liu W; Schaffhausen BS; Roberts TM
J Biol Chem; 1995 May; 270(21):12331-4. PubMed ID: 7759472
[TBL] [Abstract][Full Text] [Related]
20. The elevation of cellular phosphatidic acid levels caused by polyomavirus transformation can be disassociated from the activation of phospholipase D.
Vasudevan C; Freund R; Gorga FR
Virology; 1997 Jul; 233(2):392-401. PubMed ID: 9217062
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
